添加的内容 删除的内容
小 (机器人:清理不当的来源、移除无用的模板参数) |
小 (机器人:清理不当的来源、移除无用的模板参数) |
||
(未显示另一用户的1个中间版本) | |||
第7行: | 第7行: | ||
| location = [[波士顿]] |
| location = [[波士顿]] |
||
| key_people = Jeffrey Leiden(CEO) |
| key_people = Jeffrey Leiden(CEO) |
||
| industry = [[制药]]和[[生物技术]]<ref>{{cite web |url=http://www.hoovers.com/company/Vertex_Pharmaceuticals_Incorporated/rhytri-1.html |title=Vertex Pharmaceuticals Incorporated |publisher=[[Hoover's]] |accessdate=24 |
| industry = [[制药]]和[[生物技术]]<ref>{{cite web |url=http://www.hoovers.com/company/Vertex_Pharmaceuticals_Incorporated/rhytri-1.html |title=Vertex Pharmaceuticals Incorporated |publisher=[[Hoover's]] |accessdate=2012-06-24 }}</ref> |
||
| products = |
| products = |
||
| revenue = {{profit}} [[美元|US$]]21.7亿(2017) |
| revenue = {{profit}} [[美元|US$]]21.7亿(2017) |
||
第16行: | 第16行: | ||
== 历史 == |
== 历史 == |
||
1989年由[[约书亚·博格]]<ref name="Globe">{{cite news |title=Rearranging the Corporate DNA |first=Robert |last=Weisman |url=http://www.boston.com/business/healthcare/articles/2011/04/24/can_vertex_transform_itself_into_a_money_making_enterprise/ |newspaper=[[The Boston Globe|Boston Sunday Globe]] |date=24 |
1989年由[[约书亚·博格]]<ref name="Globe">{{cite news |title=Rearranging the Corporate DNA |first=Robert |last=Weisman |url=http://www.boston.com/business/healthcare/articles/2011/04/24/can_vertex_transform_itself_into_a_money_making_enterprise/ |newspaper=[[The Boston Globe|Boston Sunday Globe]] |date=2011-04-24 |accessdate=2012-06-25 |page=G1}}</ref>和[[凯文·J·金塞拉]]创立<ref name=molecule-book>{{cite book |last=Werth |first=Barry ||date=1994 |title=The Billion-Dollar Molecule: One Company's Quest for the Perfect Drug||location=New York |publisher=Simon & Schuster |isbn=0671510576 |oclc=32047662}} {{Google books|Pw4_sKSwizYC|The Billion-Dollar Molecule}}.</ref>。该公司主要研究和生产各类治疗绝症的[[小分子药物]],著名产品包括治疗囊性纤维化的[[伊伐卡托]]以及抗丙肝药[[特拉匹韦]]。 |
||
2019年9月3日福泰制药斥资9.5亿美元收购生物技术公司Semma Therapeutics。 |
2019年9月3日福泰制药斥资9.5亿美元收购生物技术公司Semma Therapeutics。 |
||
第22行: | 第22行: | ||
== 参考文献 == |
== 参考文献 == |
||
{{reflist}} |
{{reflist}} |
||
* {{cite book |url=http://investors.vrtx.com/secfiling.cfm?filingID=1047469-04-7993 |title=Annual Report |date=15 |
* {{cite book |url=http://investors.vrtx.com/secfiling.cfm?filingID=1047469-04-7993 |title=Annual Report |date=2004-03-15 |publisher=Vertex Pharmaceuticals |accessdate=2012-06-24 |||}} |
||
* {{cite press release |title=Vertex Completes New Drug Application for Telaprevir for Hepatitis C |url=http://investors.vrtx.com/releasedetail.cfm?ReleaseID=532555 |publisher=Vertex Pharmaceuticals |date=23 |
* {{cite press release |title=Vertex Completes New Drug Application for Telaprevir for Hepatitis C |url=http://investors.vrtx.com/releasedetail.cfm?ReleaseID=532555 |publisher=Vertex Pharmaceuticals |date=2010-11-23 |accessdate=2012-06-24}} |
||
== 外部链接 == |
== 外部链接 == |